393 related articles for article (PubMed ID: 31615517)
1. CD4
Li C; Lu Z; Bi K; Wang K; Xu Y; Guo P; Chen Y; Zhou P; Wei Z; Jiang H; Cao Y
Reprod Biol Endocrinol; 2019 Oct; 17(1):78. PubMed ID: 31615517
[TBL] [Abstract][Full Text] [Related]
2. Low mucosal-associated invariant T-cell number in peripheral blood of patients with immune thrombocytopenia and their response to prednisolone.
Maekawa T; Osawa Y; Okada Y; Tachi N; Teramoto M; Kawamura T; Horiuchi T; Kato S; Kobayashi A; Kobayashi S; Sato K; Kimura F
PLoS One; 2018; 13(11):e0207149. PubMed ID: 30408105
[TBL] [Abstract][Full Text] [Related]
3. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
[TBL] [Abstract][Full Text] [Related]
4. Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17.
Sobkowiak MJ; Davanian H; Heymann R; Gibbs A; Emgård J; Dias J; Aleman S; Krüger-Weiner C; Moll M; Tjernlund A; Leeansyah E; Sällberg Chen M; Sandberg JK
Eur J Immunol; 2019 Jan; 49(1):133-143. PubMed ID: 30372518
[TBL] [Abstract][Full Text] [Related]
5. Involvement of impaired CD8
Zhu M; Xu Y; Li C; Lu Z; Bi K; Wang K; Guo P; Jiang H; Cao Y
Reprod Biol Endocrinol; 2021 Nov; 19(1):175. PubMed ID: 34847942
[TBL] [Abstract][Full Text] [Related]
6. High MDR-1 expression by MAIT cells confers resistance to cytotoxic but not immunosuppressive MDR-1 substrates.
Fergusson JR; Ussher JE; Kurioka A; Klenerman P; Walker LJ
Clin Exp Immunol; 2018 Nov; 194(2):180-191. PubMed ID: 30231297
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of CD8 and DN MAIT Cells Among Children Diagnosed With Type 1 Diabetes Are Similar to Age-Matched Controls.
Harms RZ; Ostlund KR; Cabrera M; Edwards E; Smith VB; Smith LM; Sarvetnick N
Front Immunol; 2021; 12():604157. PubMed ID: 33708202
[TBL] [Abstract][Full Text] [Related]
8. Mucosal-Associated Invariant T Cell Deficiency in Chronic Obstructive Pulmonary Disease.
Kwon YS; Jin HM; Cho YN; Kim MJ; Kang JH; Jung HJ; Park KJ; Kee HJ; Kee SJ; Park YW
COPD; 2016; 13(2):196-202. PubMed ID: 26552490
[TBL] [Abstract][Full Text] [Related]
9. The CD4
Dias J; Boulouis C; Gorin JB; van den Biggelaar RHGA; Lal KG; Gibbs A; Loh L; Gulam MY; Sia WR; Bari S; Hwang WYK; Nixon DF; Nguyen S; Betts MR; Buggert M; Eller MA; Broliden K; Tjernlund A; Sandberg JK; Leeansyah E
Proc Natl Acad Sci U S A; 2018 Dec; 115(49):E11513-E11522. PubMed ID: 30442667
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
[TBL] [Abstract][Full Text] [Related]
11. Mucosal-associated invariant T cell deficiency in systemic lupus erythematosus.
Cho YN; Kee SJ; Kim TJ; Jin HM; Kim MJ; Jung HJ; Park KJ; Lee SJ; Lee SS; Kwon YS; Kee HJ; Kim N; Park YW
J Immunol; 2014 Oct; 193(8):3891-901. PubMed ID: 25225673
[TBL] [Abstract][Full Text] [Related]
12. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161
Yong YK; Saeidi A; Tan HY; Rosmawati M; Enström PF; Batran RA; Vasuki V; Chattopadhyay I; Murugesan A; Vignesh R; Kamarulzaman A; Rajarajeswaran J; Ansari AW; Vadivelu J; Ussher JE; Velu V; Larsson M; Shankar EM
Front Immunol; 2018; 9():472. PubMed ID: 29616020
[TBL] [Abstract][Full Text] [Related]
13. The combined action of monocytic myeloid-derived suppressor cells and mucosal-associated invariant T cells promotes the progression of cervical cancer.
Lu Z; Zhu M; Marley JL; Bi K; Wang K; Zhai M; Hu H; Guo P; Li C; Xu Y; Chen Y; Zhou P; Wei Z; Jiang H; Cao Y
Int J Cancer; 2021 Mar; 148(6):1499-1507. PubMed ID: 33245569
[TBL] [Abstract][Full Text] [Related]
14. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.
Cosgrove C; Ussher JE; Rauch A; Gärtner K; Kurioka A; Hühn MH; Adelmann K; Kang YH; Fergusson JR; Simmonds P; Goulder P; Hansen TH; Fox J; Günthard HF; Khanna N; Powrie F; Steel A; Gazzard B; Phillips RE; Frater J; Uhlig H; Klenerman P
Blood; 2013 Feb; 121(6):951-61. PubMed ID: 23255555
[TBL] [Abstract][Full Text] [Related]
15. Human blood MAIT cell subsets defined using MR1 tetramers.
Gherardin NA; Souter MN; Koay HF; Mangas KM; Seemann T; Stinear TP; Eckle SB; Berzins SP; d'Udekem Y; Konstantinov IE; Fairlie DP; Ritchie DS; Neeson PJ; Pellicci DG; Uldrich AP; McCluskey J; Godfrey DI
Immunol Cell Biol; 2018 May; 96(5):507-525. PubMed ID: 29437263
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Vα7.2+ CD161++ MAIT cell compartment in early pregnancy are associated with preterm birth in HIV-positive women.
Ravi K; Chan CYS; Akoto C; Zhang W; Vatish M; Norris SA; Klenerman P; Hemelaar J
Am J Reprod Immunol; 2020 Jun; 83(6):e13240. PubMed ID: 32255246
[TBL] [Abstract][Full Text] [Related]
17. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
[TBL] [Abstract][Full Text] [Related]
18. CD161+ MAIT cells are severely reduced in peripheral blood and lymph nodes of HIV-infected individuals independently of disease progression.
Eberhard JM; Hartjen P; Kummer S; Schmidt RE; Bockhorn M; Lehmann C; Balagopal A; Hauber J; van Lunzen J; Schulze zur Wiesch J
PLoS One; 2014; 9(11):e111323. PubMed ID: 25369333
[TBL] [Abstract][Full Text] [Related]
19. IL-7 treatment supports CD8+ mucosa-associated invariant T-cell restoration in HIV-1-infected patients on antiretroviral therapy.
Sortino O; Richards E; Dias J; Leeansyah E; Sandberg JK; Sereti I
AIDS; 2018 Mar; 32(6):825-828. PubMed ID: 29543654
[TBL] [Abstract][Full Text] [Related]
20. Association of mucosal-associated invariant T cells with different disease phases of polymyalgia rheumatica.
Nakajima S; Chiba A; Makiyama A; Hayashi E; Murayama G; Yamaji K; Kobayashi S; Tamura N; Takasaki Y; Miyake S
Rheumatology (Oxford); 2020 Oct; 59(10):2939-2946. PubMed ID: 32125422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
